Resolution of NASH and hepatic fibrosis by the GLP-1R and GCGR dual-agonist cotadutide via modulating mitochondrial function and lipogenesis
Michelle L. Boland, Rhianna C. Laker, KARLY M. MATHER, Arkadiusz Nawrocki, Stephanie Oldham, Brandon B. Boland, Hilary Lewis, James Conway, Jacqueline Naylor, Silvia Guionaud, Michael Feigh, Sanne Skovgård Veidal, Louise Lantier, Owen P. McGuinness, Joseph Grimsby, Cristina M. Rondinone, Lutz Jermutus, Martin R. Larsen, James L. Trevaskis, Christopher J. Rhodes
Topics & Concepts
LipogenesisAgonistEndocrinologyInternal medicineFunction (biology)Dual (grammatical number)Dual functionChemistryMedicineCell biologyBiologyReceptorComputer scienceLipid metabolismContouringLiteratureComputer graphics (images)ArtLiver Disease Diagnosis and TreatmentPancreatic function and diabetesMetabolism, Diabetes, and Cancer